Septerna (SEPN) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
30 Apr, 2026Executive summary
Annual meeting scheduled for June 26, 2026, to be held virtually for shareholder participation.
Shareholders are encouraged to review proxy materials and vote by June 25, 2026.
Voting matters and shareholder proposals
Election of two directors: Shalini Sharp, M.B.A., and Jake Simson, Ph.D.
Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
Other business may be addressed as appropriate during the meeting or any adjournment.
Board of directors and corporate governance
Board recommends voting in favor of all presented proposals and nominees.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Septerna
- Proxy covers director elections, auditor ratification, compensation, and governance policies.SEPN
Proxy filing30 Apr 2026 - SEP-631 advances to phase II for urticaria after strong phase I data; SEP-479 nears phase I start.SEPN
TD Cowen 46th Annual Health Care Conference29 Apr 2026 - Rapidly advancing oral GPCR therapies with strong pipeline and Novo Nordisk partnership.SEPN
Corporate presentation16 Mar 2026 - Pipeline advances and improved financials set stage for clinical milestones in 2026.SEPN
Q4 20259 Mar 2026 - SEP-631 showed strong Phase 1 safety and efficacy, advancing to Phase 2 urticaria trials in 2026.SEPN
Study result2 Mar 2026 - Lead GPCR programs advance toward clinical milestones, supported by strong platform and partnerships.SEPN
44th Annual J.P. Morgan Healthcare Conference14 Jan 2026 - Advancing oral GPCR-targeted therapies with strong clinical pipeline and Novo Nordisk partnership.SEPN
Corporate presentation13 Jan 2026 - GPCR platform drives rapid pipeline growth, with SEP786 and SEP631 clinical data expected in 2025.SEPN
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026 - SEP-479, a next-gen oral PTH1R agonist, advances with improved efficacy and safety profile.SEPN
Cantor Global Healthcare Conference 20255 Jan 2026